Skip to main content

Day: January 11, 2022

T2 Biosystems Announces the Initiation of the T2Biothreat® Panel Clinical Trial

LEXINGTON, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the initation of a U.S. clinical trial evaluating the performance of its T2Biothreat® Panel designed to support a submission to the U.S. Food and Drug Administration (FDA). The T2Biothreat® Panel, which runs on T2 Biosystems’ T2Dx® Instrument, is a direct-from-blood test panel that provides results in 3-5 hours and simultaneously detects six biothreat pathogens identified as threats by the U.S. Government, including B. anthracis, F. tularensis, Burkholderia spp., Y. pestis, and R. prowazekii. The Company plans to file the FDA submission for the T2Biothreat® Panel in 2022 following completion of the clinical trial, which includes positive samples being prepared and analyzed...

Continue reading

CEA Industries Inc. Announces New Senior Vice President of Corporate Development

Names Ryan Gift to CEA Industries Management Team Louisville, Colorado, Jan. 11, 2022 (GLOBE NEWSWIRE) — CEA Industries Inc. (the “Company”) (OTCQB: SRNA), a leader in controlled environment agriculture (CEA) systems engineering and technologies, announced today the appointment of Ryan Gift as Senior Vice President of Corporate Development of the Company, effective immediately. Mr. Gift is a seasoned M&A executive with over 15 years of leadership experience. “We are delighted to announce that Ryan will be assuming leadership of our corporate development initiatives as we continue to execute on our previously announced strategic growth plans,” said Tony McDonald, CEA Industries CEO. “I’m excited to have an executive of Ryan’s caliber to help CEA Industries achieve even greater levels of success.” Ryan adds, “I am very pleased...

Continue reading

Sun Pacific Holding Corp. announces its subsidiary Sun Pacific Power now providing Nano Solar Panels; “CIG’s industry market capacity to reach USD 8.5 billion by 2024”

MANALAPAN, N.J., Jan. 11, 2022 (GLOBE NEWSWIRE) — Sun Pacific Holding Corp. (OTC: SNPW) is pleased to announce Sun Pacific Power “NANO SOLAR” panels offering worldwide sales and capacity for up to 50 MW per year. With this new product line Sun Pacific will have the opportunity to provide nano technology and building integrated solar panels that can deliver greater efficiency. Nicholas Campanella, CEO of Sun Pacific Holding Corp. said, “We are excited to bring to the emerging renewable energy market this state-of-the-art technology to expand our solar footprint and offer Nano Solar CIGs on a worldwide level. Our product will be used for various applications and offering light weight panel technology with the option to provide various colored solar panels for building facades and reducing roof loads.” Sun Pacific Power CIGS modules...

Continue reading

“Dog the Bounty Hunter” Signs with Virtual Interactive Technologies to Develop Multiple Video Games Around His Persona

Denver, Colorado, Jan. 11, 2022 (GLOBE NEWSWIRE) — Virtual Interactive Technologies Corp., (OTC: VRVR) (“VRVR” or the “Company”), a multi-platform video gaming company, is pleased to announce that it has signed a multi-year, multi-game agreement with a production entity representing Duane “Dog” Chapman, aka “Dog the Bounty Hunter”. Virtual Interactive Technologies will develop and market a line of video games in cooperation with the production entity and will use Mr. Chapman’s name, image, and likeness in connection with the advertisement, promotion, and sale of the video games. For more than a decade, Mr. Chapman has entertained his fans with multiple hit television series. In addition to capturing over 10,000 fugitives in his career, he has also captured millions of followers on social media. Virtual Interactive Technologies...

Continue reading

Trillion Energy Comments on Natural Gas Price Increases

Natural Gas prices increase to historic highs of US$13.07/MCF VANCOUVER, British Columbia, Jan. 11, 2022 (GLOBE NEWSWIRE) — Trillion Energy International Inc. (“Trillion” or the “Company”) (CSE: TCF) (OTC: TCFF) (Frankfurt: 3P2N) recently received a price increase for sale of natural gas to approximately USD $13.07/mcf amid seasonal supply shortages and strong regional demand. The price increase was effective January 2022. In contrast this USD $13.07/mcf, the average natural gas sale price received during 2021 was approximately USD $8.84/mcf. The Company believes a trifecta of circumstances have resulted in the sudden sharp price increase, which include increased demand due to a cold winter, alternate energy sources being shut down (such as several nuclear power plants in Germany), delays in increased supply of natural gas from...

Continue reading

Matterport Appoints Rob Hines as Managing Director to Drive Growth in the Americas

Veteran sales executive from Oracle and salesforce.com to lead company’s sales to accelerate new business growth in the region SUNNYVALE, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) — Matterport, Inc. (Nasdaq: MTTR), the leading spatial data company driving the digital transformation of the built world, today announced that Rob Hines has joined the company as Managing Director, Americas. Hines will oversee sales efforts across the region, including new business and revenue growth, people management and the execution of Matterport’s strategic vision. “As we continue to innovate and expand Matterport’s products and services, it’s important that we have the right leaders in all of our high-growth markets to support our vision and capture the enormous addressable market,” said Jay Remley, Chief Revenue Officer of Matterport. “Rob’s extensive...

Continue reading

Aligos Therapeutics Expands Collaboration with Merck to Develop Oligonucleotide Therapies for NASH

SOUTH SAN FRANCISCO, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that it has expanded its ongoing collaboration agreement with Merck to discover and develop oligonucleotide therapies for non-alcoholic steatohepatitis (NASH). “We believe that one of our strengths as a company is our technical know-how in several areas of oligonucleotide research and development,” said Lawrence Blatt, Ph.D., MBA, Chairman and Chief Executive Officer of Aligos. “We are pleased to broaden our collaboration where we may be able to contribute to creating effective, targeted therapies for NASH together with Merck.” Under the original agreement, Merck and Aligos...

Continue reading

BlackLine Announces Date for Fourth Quarter and Full Year 2021 Earnings Release and Conference Call

LOS ANGELES, Jan. 11, 2022 (GLOBE NEWSWIRE) — BlackLine, Inc. (Nasdaq: BL) announced today that it will release financial results for the fourth quarter and full year ended December 31, 2021 after market close on Thursday, February 10, 2022 followed by a conference call hosted by management at 2:00 p.m. PT / 5:00 p.m. ET. A live webcast will be accessible on BlackLine’s investor relations website at https://investors.blackline.com/. The call can also be accessed domestically at (844) 229-7595 and internationally at (314) 888-4260, passcode 1426609.   A telephonic replay will be available through Thursday, February 17, 2022 at (855) 859-2056 or (404) 537-3406, passcode 1426609. A replay of the webcast will be available at https://investors.blackline.com/ for 12 months. About BlackLine Companies come to BlackLine (Nasdaq: BL) because...

Continue reading

T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2021 Results

LEXINGTON, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced preliminary unaudited financial and operational results for the fourth quarter and full year 2021. Recent Highlights (unaudited)Achieved full year 2021 total revenue of $27.7 million, including product revenue of $16.7 million, representing an increase of 53% and 43%, respectively compared to the prior year Achieved fourth quarter total revenue of $6.6 million, including fourth quarter product revenue of $4.0 million Executed contracts for 32 T2Dx® Instruments in 2021, including 17 T2Dx® Instrument contracts during the fourth quarter, consisting of 3 from the U.S. and 14 from outside the U.S. Generated full year 2021 U.S. sepsis test panel revenue of $5.1 million, representing...

Continue reading

CN to Report Fourth-Quarter and Full-Year 2021 Financial and Operating Results on January 25, 2022

MONTREAL, Jan. 11, 2022 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) will issue its fourth-quarter and full-year 2021 financial and operating results after the market close on January 25, 2022. CN’s senior officers will review the results and the railway’s outlook in a conference call starting at 4:30 p.m. Eastern Time on January 25. JJ Ruest, CN President and Chief Executive Officer, will lead the call. Parties wishing to participate via telephone may dial 1-866-324-3683 (Canada/U.S.), or 1-509-844-0959 (International), using 1523718 as the passcode. Participants are advised to dial in 10 minutes prior to the call. CN will webcast the presentation live and furnish slides supporting the officers’ remarks via the Investors section of its website at www.cn.ca/en/investors. A webcast replay will be available after...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.